How to Buy Rani Therapeutics Holdings Stock
Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics.
Rani Therapeutics Holdings stock last closed at $1.09, down 6.84% from the previous day, and has decreased 83.66% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Rani Therapeutics Holdings stock is currently +5.83% from its 52-week low of $1.03, and -86.17% from its 52-week high of $7.88.
As of Apr 21, 2025, there are 57.48M shares of RANI outstanding. The market cap of RANI is $62.66M. In the last 24 hours, 141,945 RANI shares were traded.
How to Buy Rani Therapeutics Holdings Stock
Not sure how to invest in Rani Therapeutics Holdings stock? Here's how.
- Figure out where to buy Rani Therapeutics Holdings stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Rani Therapeutics Holdings stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your method of payment and add your information.
- Evaluate Rani Therapeutics Holdings stock: The Rani Therapeutics Holdings ticker symbol is RANI. Is Rani Therapeutics Holdings stock a good investment? Should you buy shares of RANI? How do RANI's underlying business fundamentals look? Do top analysts think Rani Therapeutics Holdings is a good buy? Why has RANI's stock price moved recently? (Hint: Our stock analysis website can help you decide if RANI is a good stock to buy).
- Execute your RANI trade: Decide if you will purchase RANI shares at the current market price or use a limit order to purchase RANI shares at a specific price.
- Get notifications regarding your RANI investment: Create a watchlist to watch your new investment in Rani Therapeutics Holdings stock.
Step 1: Figure out where to buy Rani Therapeutics Holdings stock
You need an online brokerage account to access the NASDAQ market and buy RANI stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal info so you can buy RANI stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on the best stock trading app for beginners, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your new investment account.
Step 4: Evaluate Rani Therapeutics Holdings stock
After you have chosen the best place to buy Rani Therapeutics Holdings stock, it's critical to analyze their stock prior to buying, so you can wrap your head around the risk and upside.
Rani Therapeutics Holdings quick stats
Rani Therapeutics Holdings Fundamentals
WallStreetZen was created to help average investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on RANI's stock page.
Is RANI stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge RANI's fair value.
Using relative valuations ratios:
- RANI may be overvalued based on its P/B ratio of 31.45x, relative to Biotechnology industry P/B ratio of 4.04x
You can do more valuation research on RANI's stock here.
A look at RANI Cashflows and Balance Sheet
Signs that RANI is financially healthy:
- There are more short-term assets than short-term liabilities on the RANI balance sheet.
- There are more short-term assets than long-term liabilities on the RANI balance sheet.
- Total RANI debt is lower than 5 years ago, relative to shareholder equity.
Signs that RANI is not financially healthy:
- RANI profit margin has gone down from N/A to -2,920% in the past year.
- RANI has $27.64M in cash and short term investments. This is not enough to cover its annual cash burn of $35.76M.
- RANI has a relatively high debt to equity ratio of 16.64.
- RANI has cash burn of 35764000. It does not have sufficient cash and short-term investments to cover this.
Do analysts think it's a good time to buy RANI stock
Out of 3 sell side analysts who give recommendations on RANI, the consensus analyst rating on Rani Therapeutics Holdings is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Rani Therapeutics Holdings stock forecast page.
RANI Technical Indicators
RANI Earnings
Last year, RANI revenue was $1.03M. During the last 5 year, RANI's revenue has increased by 0.98% per year. This was slower than the Biotechnology industry average of 44.31%.
Find out more about RANI's earnings and revenue performance here.
What are RANI executives and large shareholders up to?
In the past year, executives and large shareholders at RANI have sold more shares than they have bought.
Kate McKinley, Chief Business Officer of RANI, was the latest RANI insider to buy. They bought $29,993.20 worth of RANI stock on Dec 13, 2024.
Research more about who owns RANI shares here.
Can I rely on RANI as an income stream?
No, Rani Therapeutics Holdings doesn't provide an income stream by paying out dividends.
What do other investors have to say about RANI?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your RANI trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given price limit, use a limit order.
Hit the Open button and eToro will place your order.
If you require additional help investing in stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your RANI investment
Now that you own some shares in RANI, you'll want to stay up-to-date on your company.
Start a watchlist to see the latest developments about your RANI stock.
RANI Feed
No news
There is no news on the companies in your watchlist or you don't have enough companies added to your list.
How to Buy Stock in Rani Therapeutics Holdings
To summarize, here are the 6 steps you need to take to buy Rani Therapeutics Holdings stock right now:
- Figure out where to buy Rani Therapeutics Holdings stock
- Create a brokerage account
- Deposit funds into your investment account
- Evaluate Rani Therapeutics Holdings stock
- Execute your RANI trade
- Get notifications regarding your RANI investment
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep tabs on your new investment in Rani Therapeutics Holdings, create a watchlist today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.